Myriad Genetics Inc (NASDAQ:MYGN)

22.52
Delayed Data
As of Mar 30
 -0.80 / -3.43%
Today’s Change
13.92
Today|||52-Week Range
28.18
+55.20%
Year-to-Date
No recent news for Myriad Genetics Inc.

Today’s Trading

Previous close23.33
Today’s open23.33
Day’s range22.46 - 23.66
Volume446,047
Average volume (3 months)696,156
Market cap$1.9B
Data as of 3:59pm ET, 03/30/2023

Growth & Valuation

Earnings growth (last year)-298.51%
Earnings growth (this year)-10.00%
Earnings growth (next 5 years)-68.57%
Revenue growth (last year)-1.77%
P/E ratioNM
Price/Sales1.72
Price/Book2.17

Competitors

----
CLDXCelldex Therapeutics...-0.38-1.06%
----
VCYTVeracyte Inc-0.86-4.01%
Data as of 3:59pm ET, 03/30/2023

Financials

Next reporting dateMay 4, 2023
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$678.4M
Annual profit (last year)-$112.0M
Net profit margin-16.51%

Profile

Sector
Health Technology
Industry
Medical Specialties
No executives to display
Corporate headquarters
Salt Lake City, Utah

Forecasts